MODAKEM – potency enhancement supplement | Buy in Ukraine with delivery

What is MODAKEM?

MODAKEM is a modern medicinal product belonging to the group of non-steroidal anti-inflammatory drugs (NSAIDs) for systemic use. The main purpose of the drug is to relieve pain, reduce the intensity of the inflammatory process, and normalize elevated body temperature. The pharmacological action of MODAKEM is due to its ability to selectively act on enzyme systems of the body responsible for the synthesis of inflammatory mediators. The drug is available in the form of tablets for oral administration, which ensures convenience of intake in an outpatient setting. Due to an optimal safety profile and a rapid onset of therapeutic effect, MODAKEM is widely used in clinical practice by physicians of various specialties.

The manufacturer of MODAKEM is a pharmaceutical company with years of experience in producing medicines in accordance with international GMP quality standards. The technological manufacturing process of the drug involves strict control at all stages — from the synthesis of the active substance to the packaging of the finished product. Each batch of MODAKEM undergoes mandatory testing for compliance with pharmacopoeial requirements regarding purity, stability, and bioavailability. Such an approach guarantees identical therapeutic efficacy of each tablet regardless of the release batch. The drug is registered in Ukraine in accordance with current legislation and approved for medical use.

MODAKEM belongs to the category of prescription drugs, which highlights the need for prior consultation with a physician before starting therapy. This status is due to the potent pharmacological activity of the active substance and the potential risk of developing adverse reactions in uncontrolled use. A physician evaluates the benefit-to-risk ratio for each patient individually, considering comorbid conditions, age, and the functional state of the liver and kidneys. Self-medication with MODAKEM is unacceptable, as it can lead to serious complications involving the gastrointestinal tract and the cardiovascular system. Proper use of the drug under medical supervision ensures maximum efficacy with a minimal risk of unwanted events.

What is MODAKEM prescribed for?

MODAKEM is prescribed for the symptomatic treatment of pain syndromes of various etiologies and intensities. The drug effectively relieves acute pain in injuries of the musculoskeletal system, ligament sprains, soft tissue contusions, and postoperative conditions. Clinical studies confirm a rapid reduction in painful sensations within the first hour after taking a tablet. The duration of the analgesic effect allows for maintaining the patient's comfortable state throughout the entire day. The possibility of using MODAKEM for pain accompanied by a pronounced inflammatory component is particularly important.

The second important area of MODAKEM application is chronic inflammatory joint diseases — osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis. In these pathologies, the drug not only reduces pain but also slows down the progression of the inflammatory process in joint tissues. Regular intake of MODAKEM helps reduce morning stiffness, improve joint mobility, and enhance the quality of life of patients. The therapeutic effect in chronic diseases develops gradually and reaches its peak after several days of systematic use. A physician may recommend a long-term course of treatment with periodic monitoring of laboratory parameters.

MODAKEM is also used to treat dysmenorrhea — painful menstruation in women of reproductive age. The drug reduces the intensity of uterine contractions and decreases the level of prostaglandins, which are the main cause of pain during this period. In addition, MODAKEM is effective for dental pain, tension headaches, and mild to moderate migraines. In all cases, the drug acts symptomatically, meaning it relieves manifestations of the disease but does not affect its underlying cause. Therefore, MODAKEM should be considered as part of a comprehensive therapy prescribed by a doctor after establishing an accurate diagnosis.

Composition and active components of MODAKEM

The active pharmaceutical ingredient of MODAKEM is meloxicam — a substance from the oxicam group, belonging to selective cyclooxygenase-2 inhibitors. Meloxicam selectively blocks the COX-2 enzyme, which is responsible for prostaglandin synthesis at the site of inflammation, while exerting a minimal effect on COX-1, which protects the gastric mucosa. This mechanism of action provides a pronounced anti-inflammatory and analgesic effect with a significantly lower risk of developing gastropathies compared to non-selective NSAIDs. The bioavailability of meloxicam upon oral administration is about 89%, which guarantees a stable concentration of the drug in the blood. Maximum plasma concentration is reached 5–6 hours after taking the tablet.

MODAKEM contains excipients that ensure the stability of the drug, accurate dosing, and appropriate pharmacokinetic characteristics. Among them is microcrystalline cellulose, which acts as a filler and provides mechanical strength to the tablet. Lactose monohydrate is used as a binding component that facilitates the tableting process and improves tablet disintegration in the gastrointestinal tract. Croscarmellose sodium acts as a disintegrant, accelerating the release of the active substance after the tablet enters the stomach. Magnesium stearate serves as a lubricant that prevents the powder mass from sticking to the compression equipment.

The mechanism of action of MODAKEM is realized through the inhibition of prostaglandin synthesis — biologically active substances that play a key role in the development of inflammation, pain, and fever. Decreasing the concentration of prostaglandins in peripheral tissues leads to a reduction in swelling, redness, and pain sensitivity. In the central nervous system, the drug increases the threshold of pain sensitivity, which further enhances the analgesic effect. An important feature of MODAKEM is its long elimination half-life of about 20 hours, allowing for once-daily dosing. A stable concentration of meloxicam in the blood provides a consistent therapeutic effect throughout the entire treatment period.

MODAKEM Dosage

The standard recommended dose of MODAKEM for adult patients is 7.5 mg once daily. This dose is optimal for most clinical situations and provides a sufficient therapeutic effect with a minimal risk of adverse reactions. In case of severe pain syndrome or a severe course of the inflammatory process, a physician may increase the dose up to 15 mg daily. The maximum daily dose should not exceed 15 mg, as a further increase in dose does not lead to an enhancement of the therapeutic effect, but significantly increases the likelihood of developing adverse events. Dosing is selected individually, taking into account the severity of the disease, the age of the patient, and the presence of comorbid pathology.

For elderly patients over 65 years of age, the recommended starting dose of MODAKEM is 7.5 mg per day. This is due to an age-related decline in renal and hepatic function, which slows down the excretion of the drug from the body and increases the risk of accumulation. Patients with mild to moderate renal impairment do not require dose adjustment, but regular monitoring of creatinine clearance is necessary. In severe renal failure, the use of MODAKEM is contraindicated. Patients with mild hepatic impairment do not require dose adjustment, but periodic monitoring of liver transaminases is recommended.

The duration of the MODAKEM treatment course is determined by a physician depending on the nature and course of the disease. For acute pain, the drug is usually used for 3–7 days until a sustained analgesic effect is achieved. In chronic inflammatory joint diseases, the treatment course may last several weeks or months with periodic evaluation of the therapy's efficacy and safety. It is important not to exceed the recommended duration of use without consulting a doctor, as prolonged intake of NSAIDs is associated with an increased risk of cardiovascular complications. The decision to continue therapy is made based on the dynamics of clinical symptoms and the results of laboratory tests.

How to take MODAKEM correctly?

MODAKEM should be taken once daily, preferably at the same time every day, which ensures a stable concentration of the drug in the blood. The tablet must be swallowed whole, without chewing or crushing, with a sufficient amount of water — at least half a glass. Taking the drug is recommended during or immediately after a meal, which reduces the irritant effect on the gastric mucosa. Despite the selectivity of meloxicam towards COX-2, following this rule further reduces the risk of dyspeptic events. The tablet should not be split into parts, as this may compromise dosing accuracy and affect the rate of active substance release.

If a regular dose of MODAKEM is missed, the drug should be taken as soon as possible if more than 12 hours remain until the next scheduled intake. If the next intake is expected in less than 12 hours, the missed dose should be skipped, and the patient should return to the normal schedule. Doubling the dose is strictly prohibited to compensate for a missed one, as this significantly increases the risk of toxic reactions. Patients who frequently forget to take their medication are advised to set a reminder on a mobile phone or link the drug intake to a specific daily routine, such as breakfast. Maintaining regularity of intake is a key factor in achieving a stable therapeutic effect.

During MODAKEM treatment, patients are advised to abstain from consuming alcoholic beverages, as ethanol potentiates the ulcerogenic effect of the drug on the mucosa of the gastrointestinal tract. It is also important to ensure adequate fluid intake throughout the day to support normal kidney function. Patients with arterial hypertension need to regularly monitor their blood pressure, as NSAIDs may reduce the efficacy of antihypertensive drugs. If any unusual symptoms appear — abdominal pain, black stools, edema, shortness of breath — you should immediately stop taking the drug and seek medical help. The body's individual response to MODAKEM may vary, so it is important to carefully observe your well-being throughout the treatment course.

Side effects of MODAKEM

The most common side effects of MODAKEM are gastrointestinal disorders, occurring in approximately 5–10% of patients. These include dyspepsia, nausea, abdominal pain, flatulence, diarrhea, or constipation. These symptoms are usually mild to moderate in nature, occur at the start of therapy, and gradually diminish with continued treatment. Less frequently, erosive and ulcerative lesions of the gastric and duodenal mucosa are observed, which may manifest as occult bleeding or anemia. For patients with risk factors for gastropathies, a doctor may prescribe concomitant therapy with proton pump inhibitors to protect the mucosa. If severe abdominal pain, vomiting with blood, or black stools occur, it is necessary to immediately stop taking the drug and consult a doctor.

On the part of the cardiovascular system, MODAKEM can cause increased blood pressure, peripheral edema, and aggravation of heart failure. These effects are due to sodium and water retention in the body resulting from the inhibition of renal prostaglandin synthesis. The risk of cardiovascular complications increases with prolonged use of the drug, in patients with ischemic heart disease, a history of myocardial infarction, or stroke. For patients with high cardiovascular risk, MODAKEM is prescribed with caution, in the lowest effective dose, and for the shortest possible duration. Regular monitoring of blood pressure and body weight is recommended during treatment, especially in the first weeks of therapy.

Rare adverse reactions of MODAKEM include impaired liver and kidney function, manifested by increased levels of transaminases, creatinine, and urea in the blood. These changes are usually transient and disappear after drug discontinuation, but they require laboratory monitoring. Allergic reactions — skin rash, itching, urticaria, angioedema — occur rarely, but require immediate medical attention. From the nervous system, headache, dizziness, drowsiness, or insomnia are possible, which usually resolve on their own. Patients should remember that the body's individual response to the drug can be unpredictable, so any unusual symptoms are a reason to consult a doctor.

Contraindications of MODAKEM

MODAKEM has a clear list of absolute contraindications, in the presence of which the use of the drug is strictly forbidden. These include hypersensitivity to meloxicam or any excipient component, as well as a known allergy to other nonsteroidal anti-inflammatory drugs, including acetylsalicylic acid. The drug is contraindicated in patients with active gastric and duodenal peptic ulcer disease, gastrointestinal bleeding, or perforation in history related to NSAID use. Severe hepatic impairment, severe renal failure without dialysis, and severe heart failure are also absolute contraindications to the use of MODAKEM. The drug is not prescribed to patients with bleeding disorders and active bleeding of any localization.

Pregnancy is an absolute contraindication to the use of MODAKEM, especially in the third trimester, when the drug can cause premature closure of the ductus arteriosus in the fetus, renal dysfunction, and inhibition of labor. In the first and second trimesters, the drug is prescribed only in exceptional cases when the expected benefit to the mother outweighs the potential risk to the fetus. MODAKEM is contraindicated during breastfeeding, as meloxicam passes into breast milk and can negatively affect the infant. The drug is not prescribed to children and adolescents under 16 years of age due to the lack of sufficient data on safety and efficacy in this age group. Women of reproductive age planning a pregnancy should inform their doctor before starting therapy.

Relative contraindications to the use of MODAKEM are conditions in which the drug may be prescribed with caution and under close medical supervision. These include coronary artery disease, cerebrovascular diseases, peripheral arterial disease, arterial hypertension, dyslipidemia, and diabetes mellitus. For patients with mild to moderate chronic heart failure, MODAKEM is prescribed only after a careful assessment of the benefit-to-risk ratio. Advanced age, smoking, alcohol abuse, concomitant use of anticoagulants and corticosteroids increase the risk of complications and require special attention. Before starting treatment with MODAKEM, the patient is obliged to inform the doctor about all existing diseases and medications taken to avoid dangerous interactions.

Interaction of MODAKEM with other drugs and alcohol

MODAKEM enters into clinically significant interactions with a number of medicinal products, which requires informing the doctor about all medications taken by the patient. Concurrent use of MODAKEM with anticoagulants — warfarin, heparin, novel oral anticoagulants — significantly increases the risk of bleeding due to a synergistic effect on the blood coagulation system. Combination with other NSAIDs, including acetylsalicylic acid even at low doses, significantly increases the likelihood of gastrointestinal ulcerative lesions. Concomitant use with corticosteroids and selective serotonin reuptake inhibitors also increases the risk of gastrointestinal bleeding. MODAKEM can reduce the efficacy of diuretics and antihypertensive drugs — ACE inhibitors, angiotensin receptor blockers, beta-blockers, requiring monitoring of blood pressure and kidney function.

Alcohol consumption during treatment with MODAKEM is strictly contraindicated, as ethanol potentiates the ulcerogenic effect of the drug and increases the risk of gastrointestinal bleeding. Combining alcohol with MODAKEM creates an additional load on the liver, which can lead to toxic damage to hepatocytes. Patients taking MODAKEM should refrain from driving vehicles and operating machinery if dizziness, drowsiness, or impaired concentration occur. These symptoms are more likely to occur at the start of therapy or with an increase in dose. MODAKEM can interact with lithium preparations, increasing its concentration in the blood to toxic levels, which requires monitoring of lithium levels during combined use. Also, the drug may reduce the efficacy of intrauterine contraceptive devices, which should be kept in mind by women of reproductive age.

Where to buy MODAKEM in Ukraine

MODAKEM is available in pharmacy chains of Ukraine by a doctor's prescription, which ensures controlled and safe use of the drug. The drug can be purchased both in brick-and-mortar pharmacies and via online medication booking services followed by pickup at a pharmacy point. The availability of MODAKEM in a specific pharmacy depends on the region and procurement volumes, so patients are advised to check product availability in advance by phone or through online catalogs. The price of MODAKEM may vary across different pharmacy chains, so it is advisable to compare costs before purchasing. The drug is dispensed exclusively by prescription, confirming the need for a prior consultation with a doctor to obtain a prescription.

MODAKEM should be stored in its original packaging at a temperature not exceeding 25 degrees Celsius, in a dry place protected from light and out of reach of children. The shelf life of the drug is 3 years from the date of manufacture, after which use is strictly prohibited. You should not use the drug if the integrity of the packaging is compromised or if the tablets have changed their appearance. Patients who travel are recommended to transport MODAKEM in its original packaging along with the prescription to avoid misunderstandings during customs control. Before starting the use of MODAKEM, it is necessary to carefully read the full prescribing information and consult a doctor regarding the appropriateness and safety of therapy in each specific case.